MSF provides in nearly 60 countries to people whose survival of violence.

About MSF – Doctors Without Borders / M decins Sans Fronti res is an international medical humanitarian organization founded in 1971? Today, MSF provides in nearly 60 countries to people whose survival of violence, neglect, or catastrophe, threatened primarily due to armed conflict, epidemics, malnutrition, exclusion from health care or natural disasters. MSF provides independent, impartial assistance to those most in need. MSF reserves the right to speak, to bring attention to neglected crises, to challenge inadequacies or abuse of the aid system, and to advocate for improved medical treatments and protocols.

Haemolymphatic the initial stage of the disease often goes undiagnosed because there are only a few differential clinical symptoms. If left untreated, the disease is in advanced meningo – encephalitic stage . This stage 2 disease causes neuropsychiatric problems, convulsions and severe insomnia, these symptoms eventually lead to coma. Without appropriate treatment, the disease is always fatal. HAS is a large burden on communities and individual households. In 2002 , the WHO estimated that about 1.5 million were lost disability – adjusted life years due to HAS.Mr. Walbert continued, ‘While we have attained content any questions related to the positive benefits / risk assessment in the oral declaration encounter with the CHMP January 2008, we direct as agreed by the were invited CHMP has recommended with SAG -O and the CHMP in November to certain outstanding issues in the context of assessing addressing by the rapporteur and co-rapporteur. We welcome the opportunity for presenting both the SAG -O and the CHMP for to L-MTP-PE MAA review and us are hopeful that L-MTP-PE provides significant survival benefit osteosarcoma patients and is an important unrequited medical need. ‘.

L – MTP-PE was grant orphan drug status in European in 2004. The MAA for L – MTP-PE was submitted to EMEA and accept under regulatory review in November 2006.